Clincosm LogoSign in Get a demo

major depressive disorder

Showing NaN - NaN of 70
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

MDD Trial in United States (Placebo, Vilazodone)

Completed
Has Results
  • Major Depressive Disorder
  • Imperial, California
  • +51 more
Dec 6, 2019

MDD Trial in Canada, United States (Vilazodone)

Completed
Has Results
  • Major Depressive Disorder
  • Birmingham, Alabama
  • +55 more
Sep 10, 2019

MDD Trial in Puerto Rico, United States (Cariprazine, Antidepressant Therapy (ADT))

Completed
Has Results
  • Major Depressive Disorder
  • Tucson, Arizona
  • +89 more
Jul 29, 2019

MDD Trial in Australia, Canada, United States (High Dose ALKS 5461, Low Dose ALKS 5461, Placebo)

Completed
Has Results
  • Major Depressive Disorder
  • High Dose ALKS 5461
  • +2 more
  • Birmingham, Alabama
  • +48 more
Aug 2, 2019

MDD Trial in United States (ALKS 5461, Placebo)

Completed
Has Results
  • Major Depressive Disorder
  • ALKS 5461
  • Placebo
  • Tucson, Arizona
  • +26 more
Apr 26, 2019

MDD Trial in Mexico, United States (desvenlafaxine succinate sustained release, fluoxetine, )

Completed
Has Results
  • Major Depressive Disorder
  • desvenlafaxine succinate sustained release
  • +2 more
  • Dothan, Alabama
  • +42 more
Jan 2, 2019

MDD Trial in Worldwide (ALKS 5461)

Completed
Has Results
  • Major Depressive Disorder
  • ALKS 5461
  • Birmingham, Alabama
  • +157 more
Nov 21, 2018

MDD Trial in Worldwide (LY2216684, Placebo, SSRI)

Completed
Has Results
  • Major Depressive Disorder
  • Redlands, California
  • +76 more
Mar 16, 2018

MDD Trial in United States (vilazodone)

Completed
Has Results
  • Major Depressive Disorder
  • Garden Grove, California
  • +37 more
Aug 22, 2017

MDD Trial in United States (paroxetine CR)

Completed
  • Major Depressive Disorder
  • paroxetine CR
  • Birmingham, Alabama
  • +70 more
Sep 8, 2017

MDD Trial in Chile, United States (DVS SR)

Completed
Has Results
  • Major Depressive Disorder
  • DVS SR
  • Birmingham, Alabama
  • +35 more
Jun 28, 2017

MDD Trial in Chile, Mexico, United States (Desvenlafaxine Succinate Sustained-Release, Placebo)

Completed
Has Results
  • Major Depressive Disorder
  • Desvenlafaxine Succinate Sustained-Release
  • Placebo
  • Birmingham, Alabama
  • +41 more
Jan 30, 2017

MDD Trial in Mexico, United States (DVS SR)

Completed
Has Results
  • Major Depressive Disorder
  • DVS SR
  • Dothan, Alabama
  • +34 more
Dec 16, 2016

MDD Trial in Worldwide (Placebo, RO4917523 0.5 mg, RO4917523 1.5 mg)

Completed
  • Major Depressive Disorder
  • Placebo
  • +2 more
  • Little Rock, Arkansas
  • +75 more
Nov 1, 2016

MDD Trial in United States (EB-1010 25mg BID, SSRI Active, EB-1010 50mg BID)

Completed
  • Major Depressive Disorder
  • EB-1010 25mg BID
  • +3 more
  • Arcadia, California
  • +42 more
Nov 5, 2015

MDD Trial in United States (OPC-34712, Placebo, ADT)

Completed
Has Results
  • Major Depressive Disorder
  • Birmingham, Alabama
  • +42 more
Sep 30, 2015

MDD Trial in Worldwide (Placebo, Vilazodone)

Completed
  • Major Depressive Disorder
  • Beverly Hills, California
  • +74 more
May 15, 2015

MDD Trial in United States (Vilazodone, Placebo to citalopram, Placebo to vilazodone)

Completed
Has Results
  • Major Depressive Disorder
  • Birmingham, Alabama
  • +53 more
Aug 6, 2014

MDD Trial in United States (Placebo, Escitalopram, JNJ-18038683)

Completed
  • Major Depressive Disorder
  • Placebo
  • +2 more
  • Little Rock, Arkansas
  • +25 more
Aug 1, 2014

MDD, Depression Trial in India, Puerto Rico, United States (TC-5214, Placebo)

Completed
Has Results
  • Major Depressive Disorder
  • Depression
  • Birmingham, Alabama
  • +98 more
Mar 14, 2014

MDD Trial in United States (Escitalopram)

Completed
Has Results
  • Major Depressive Disorder
  • Dothan, Alabama
  • +15 more
Jan 31, 2014

MDD Trial in United States (desvenlafaxine succinate sustained-release 50 mg/day, desvenlafaxine succinate sustained-release 100

Completed
Has Results
  • Major Depressive Disorder
  • desvenlafaxine succinate sustained-release 50 mg/day
  • +2 more
  • Phoenix, Arizona
  • +60 more
Dec 17, 2013

MDD Trial in United States (Selegiline Transdermal System, Placebo)

Completed
Has Results
  • Major Depressive Disorder
  • Selegiline Transdermal System
  • Placebo
  • Dothan, Alabama
  • +19 more
Dec 12, 2013

MDD Trial in Worldwide (Vortioxetine)

Completed
Has Results
  • Major Depressive Disorder
  • Beverly Hills, California
  • +91 more
Oct 24, 2013

MDD Trial in United States (Aripiprazole+ ADT, Placebo+ ADT)

Completed
Has Results
  • Major Depressive Disorder
  • Aripiprazole+ ADT
  • Placebo+ ADT
  • Birmingham, Alabama
  • +33 more
Nov 7, 2013